Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Clinical and economic benefits of bivalent Respiratory syncytial virus prefusion F (RSVpreF) vaccine for prevention of RSV in adults: a cost-effectiveness analysis for Singapore.

BACKGROUND Respiratory syncytial virus (RSV) is a common virus causing severe illness in adults. RSV prefusion F protein subunit (RSVpreF) vaccine was approved by the Singapore Health Sciences Authority for adults aged 18-59 years at increased risk and for adults aged ≥ 60 years, to prevent RSV-associated lower respira...

K. Thakkar, A. Shajarizadeh, Nishu Gaind et al. · 0 citations
Review Open access Sep 2026

Barriers and facilitators to successful implementation of cost-effective interventions and the development of the Achieving Cost-Effectiveness in ICU (ACE-ICU) self-assessment toolkit: an international, multidisciplinary modified eDelphi study

Cost-effective interventions balance clinical benefits with economic considerations. Several cost-effective interventions in intensive care unit (ICU) settings have been identified, yet little is known about optimal implementation strategies. The aim of this study was to identify barriers and facilitators to the...

Amit Kansal, J. Latour, Sumeet Rai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.